참고문헌 (32)

1. Dev Biol Stand DM Asher 100 103 1999 Asher DM (1999) The transmissible spongiform encephalopathy agents: concerns and responses of United States regulatory agencies in maintaining the safety of biologics. Dev Biol Stand 100:103-118 

   상세보기

2. J Virol FC Bender 77 9542 2003 10.1128/JVI.77.17.9542-9552.2003 Bender FC, Whitbeck JC, de Leon MP, Lou H, Eisenbery RJ, Cohen GH (2003) Specific association of glycoprotein B with lipid rafts during Herpes Simplex Virus entry. J Virol 77:9542-9552 

   상세보기

3. Biotechnol Bioeng JM Berry 62 12 1999 10.1002/(SICI)1097-0290(19990105)62:1<12::AID-BIT2>3.0.CO;2-G Berry JM, Barnabe N, Coombe KM, Butler M (1999) Production of reovirus type-1 and type-3 from Vero cells grown on solid and macroporous microcarriers. Biotechnol Bioeng 62:12-19 

   상세보기

4. Virology G Brown 338 69 2005 10.1016/j.virol.2005.05.004 Brown G, Rixon HWM, Steel J, McDonald TP, Pitt AR, Graham S, Sugrue RJ (2005) Evidence for an association between heat shock protein 70 and the respiratory syncytial virus polymerase complex within lipid-raft membranes during virus infection. Virology 338:69-80 

   상세보기

5. Dev Biol Stand P Castle 99 191 1999 Castle P, Robertson JS (1999) Animal sera, animal sera derivatives and substitutes used in the manufacture of pharmaceuticals: viral safety and regulatory aspects. Dev Biol Stand 99:191-196 

   상세보기

6. Dev Biol Stand GA Erickson 70 59 1989 Erickson GA, Landgraf JG, Wessman SJ, Koski TA, Moss LM (1989) Detection and elimination of adventitious agents in continuous cell lines. Dev Biol Stand 70:59-66 

   상세보기

7. Virology JA Feller 275 190 2000 10.1006/viro.2000.0535 Feller JA, Smallwood S, Skiadopoulos MH, Murphy BR, Moyer SA (2000) Comparison of identical temperature-sensitive mutations in the l polymerase proteins of Sendai and Parainfluenza 3 viruses. Virology 275:190-201 

   상세보기

8. Cytotechnology DN Galbraith 39 117 2002 10.1023/A:1022935117274 Galbraith DN (2002) Transmissible spongiform encephalopathies and tissue cell culture. Cytotechnology 39:117-124 

   상세보기

9. N Engl J Med CD Hall 344 1917 2001 10.1056/NEJM200106213442507 Hall CD (2001) Respiratory syncytial virus and parainfluenza virus. N Engl J Med 344:1917-1927 

   상세보기

10. J Virol AA Haller 74 11626 2000 10.1128/JVI.74.24.11626-11635.2000 Haller AA, Miller T, Mitiku M, Coelingh K (2000) Expression of the surface glycoproteins of human parainfluenza virus type 3 by bovine parainfluenza virus type 3, a novel attenuated virus vaccine vector. J Virol 74:11626-11635 

    상세보기

11. J Gen Virol AA Haller 84 2153 2003 10.1099/vir.0.19079-0 Haller AA, Mitiku M, MacPhail M (2003) Bovine parainfluenza virus type 3 (PIV3) expressing the respiratory syncytial virus (RSV) attachment and fusion proteins protects hamsters from challenge with human PIV3 and PSV. J Gen Virol 84:2153-2162 

    상세보기

12. Biotechnol Bioeng O Henry 86 765 2004 10.1002/bit.20074 Henry O, Dormond E, Perrier M, Kamen A (2004) Insights into adenoviral vector production kinetics in acoustic filter-based perfusion cultures. Biotechnol Bioeng 86:765-774 

    상세보기

13. Biotechnol Bioeng WS Hu 30 548 1987 10.1002/bit.260300412 Hu WS, Wang DIC (1987) Selection of microcarrier diameter for the cultivation of mammalian cells on microcarriers. Biotechnol Bioeng 30:548-557 

    상세보기

14. Gene Ther LCM Kaptein 4 172 1997 10.1038/sj.gt.3300373 Kaptein LCM, Greijer AE, Valerio D, van Beusechem VW (1997) Optimized conditions for the production of recombinant amphotropic retroviral vector preparations. Gene Ther 4:172-176 

    상세보기

15. J Gene Med A Kamen 6 S184 2004 10.1002/jgm.503 Kamen A, Henry O (2004) Development and optimization of an adenovirus production process. J Gene Med 6:S184-S192 

    상세보기

16. Hum Gene Ther H Kotani 5 19 1994 10.1089/hum.1994.5.1-19 Kotani H, Newton PB, Zhang S, Chiang YL, Otto E, Weaver L, Blaese RM, Anderson WF, McGarrity GJ (1994) Improved methods of retroviral vector transduction and production for gene therapy. Hum Gene Ther 5:19-28 

    상세보기

17. Appl Microbiol Biotechnol SG Lee 45 477 1996 10.1007/BF00578459 Lee SG, Kim S, Robbins PD, Kim BG (1996) Optimization of environmental factors for the production and handling of recombinant retrovirus. Appl Microbiol Biotechnol 45:477-483 

    상세보기

18. Cytotechnology J Litwin 10 169 1992 10.1007/BF00570893 Litwin J (1992) The growth of Vero cells in suspension as cell-aggregates in serum-free media. Cytotechnology 10:169-174 

    상세보기

19. Dev Biol Stand BJ Montagnon 70 27 1989 Montagnon BJ (1989) Polio and rabies vaccines produced in continuous cell lines: a reality for Vero cell line. Dev Biol Stand 70:27-47 

    상세보기

20. Dev Biol Stand BJ Montagnon 93 119 1998 Montagnon BJ, Vincent-Falquet JC (1998) Experience with the Vero cell line. Dev Biol Stand 93:119-123 

    상세보기

21. Biotechnol Bioeng I Nadeau 77 91 2002 10.1002/bit.10128 Nadeau I, Gilbert PA, Jacob D, Perrier M, Kamen A (2002) Low-protein medium affects the 293SF central metabolism during growth and infection with adenovirus. Biotechnol Bioeng 77:91-104 

    상세보기

22. Biotechnol Adv I Nadeau 20 475 2003 10.1016/S0734-9750(02)00030-7 Nadeau I, Kamen A (2003) Production of adenovirus vector for gene therapy. Biotechnol Adv 20:475-489 

    상세보기

23. J Virol MH Skiadopoulos 73 1374 1999 10.1128/JVI.73.2.1374-1381.1999 Skiadopoulos MH, Surman S, Tatem JM, Paschalis M, Wu SL, Udem SA, Durbin P, Collins PL, Murphy BR (1999) Identification of mutations contributing to the temperature-sensitive, cold-adapted, and attenuation phenotypes of the live-attenuated, cold-passaged 45 (cp45) human parainfluenza virus 3 candidate vaccine. J Virol 73:1374-1381 

    상세보기

24. J Virol RS Tang 77 10819 2003 10.1128/JVI.77.20.10819-10828.2003 Tang RS, Schickli JH, MacPhail M, Fernandes F, Bicha L, Spaete J, Fouchier RAM, Osterhaus ADME, Spaete R, Haller AA (2003) Effects of human metapneumovirus and respiratory syncytial virus antigen insertion in two 3′ proximal genome positions of bovine/human parainfluenza virus type 3 on virus replication and immunogenicity. J Virol 77:10819-10828 

    상세보기

25. J Virol RS Tang 78 11198 2004 10.1128/JVI.78.20.11198-11207.2004 Tang RS, MacPhail M, Schickli JH, Kaur J, Robinson CL, Lawlor HA, Guzzetta JM, Spaete RR, Haller AA (2004) Parainfluenza virus type 3 expressing the native or soluble fusion (F) protein of respiratory syncytial virus (RSV) confers protection from RSV infection in African green monkeys. J Virol 78:11198-11207 

    상세보기

26. Dev Biol Stand JC Vincent-Falquet 70 153 1989 Vincent-Falquet JC, Peyron L, Souvras M, Moulin JC, Tektoff J, Patet J (1989) Qualification of working cell banks for the Vero cell line to produce licensed human vaccines. Dev Biol Stand 70:153-156 

    상세보기

27. Exp Cell Res GM Williams 89 139 1974 10.1016/0014-4827(74)90196-7 Williams GM, Gunn JM (1974) Long-term cell culture of adult rat liver epithelial cells. Exp Cell Res 89:139-142 

    상세보기

28. WHO Tech Rep Ser World Health Organization 745 99 1987a World Health Organization (1987a) Requirements for continuous cell lines used for biological substances. WHO Tech Rep Ser 745:99-115 

29. WHO Tech Rep Ser World Health Organization 760 167 1987b World Health Organization (1987b) Requirements for rabies vaccine (inactivated) for human use produced in continuous cell lines. WHO Tech Rep Ser 760:167-189 

30. Vaccine SC Wu 22 3858 2004 10.1016/j.vaccine.2004.05.037 Wu SC, Liu CC, Lian WC (2004) Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development. Vaccine 22:3858-3864 

    상세보기

31. Biotechnol Bioeng AY Yokomizo 85 506 2004 10.1002/bit.10917 Yokomizo AY, Antoniazzi MM, Galdino PL, Azambunja N Jr, Jorge SAC, Pereira CA (2004) Rabies virus production in high Vero cell density cultures on macroporous microcarriers. Biotechnol Bioeng 85:506-515 

    상세보기

32. Biotechnol Bioeng IH Yuk 86 637 2004 10.1002/bit.20158 Yuk IH, Olsen MM, Geyer S, Forestell SP (2004) Perfusion cultures of human tumor cells: a scalable production platform for oncolytic adenoviral vectors. Biotechnol Bioeng 86:637-642 

    상세보기